How to find data

Select the required Time Period using the filter above
Choose the Commodity you need using the search bar or navigation tree (6,000+ items)
Select the Reporter, Partner and Trade Flow you want
Choose the visualization type
Customize your table or chart using the Settings button
Save your results as an image or data file using the Download button

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products | Imports and Exports | 2023

TABLE

LINE

COLUMN

PIE

MAP

Settings

Save query

Download

PNG
JPG
SVG

XLSX
XLSX (flat table)
XLSX (time series)

$Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products | Imports and Exports | 2023$

In 2023, the world exports of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" exceeded $312 billion (according to external trade statistics of 118 countries). It was $324 billion in the previous year (according to merchandise trade statistics of 123 countries).

There are no trade data (2023) for such exporters as Korea (1.61% of the world exports in 2022), Vietnam (0.004%)

Top exporters of Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc in 2023

The world's largest exporters of this commodity group in 2023:

Switzerland - 16.7% of the world exports ($52 billion)
USA - 15.9% ($49 billion)
Germany - 14.9% ($46 billion)
Ireland - 14.2% ($44 billion)
Belgium - 9.35% ($29 billion)

«Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc» accounted for a substantial share of total exports of

Ireland - 20% of Ireland's total exports in 2023 ($44 billion of $212 billion)
Switzerland - 12.4% ($52 billion of $419 billion)
Belgium - 7.43% ($29 billion of $393 billion)
Austria - 4.69% ($10.1 billion of $216 billion)
Denmark - 3.45% ($4.7 billion of $136 billion)
Sweden - 2.93% ($5.8 billion of $197 billion)

According to statistics provided by the major exporters, the largest flows of exports of «Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc» in 2023:

Exports from Belgium to USA: (2.55% of the world exports, $7.97 billion according to external trade statistics of Belgium)
Exports from Germany to USA: (4.51% of the world exports, $14 billion according to external trade statistics of Germany)
Exports from Ireland to Belgium: (2.68% of the world exports, $8.39 billion according to external trade statistics of Ireland)
Exports from Ireland to Netherlands: (2.35% of the world exports, $7.34 billion according to external trade statistics of Ireland)
Exports from Ireland to USA: (4.62% of the world exports, $14.4 billion according to external trade statistics of Ireland)
Exports from Switzerland to Germany: (2.45% of the world exports, $7.65 billion according to external trade statistics of Switzerland)
Exports from Switzerland to USA: (5.45% of the world exports, $17 billion according to external trade statistics of Switzerland)
Exports from USA to Belgium: (1.78% of the world exports, $5.58 billion according to external trade statistics of USA)
Exports from USA to China: (1.73% of the world exports, $5.41 billion according to external trade statistics of USA)
Exports from USA to Netherlands: (1.87% of the world exports, $5.85 billion according to external trade statistics of USA)

In 2023, the world imports of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" exceeded $317 billion (according to external trade statistics of 135 countries). It was $312 billion in the previous year (according to merchandise trade statistics of 140 countries).

There are no trade data (2023) for such importers as Korea (1.47% of the world imports in 2022), Vietnam (0.363%), Angola (0.109%), Nepal (0.062%), Cambodia (0.031%), State of Palestine (0.015%), Mongolia (0.007%), Trinidad and Tobago (0.005%), Burundi (0.003%), Lesotho (0.003%), Rwanda (0.002%), Timor-Leste (0.001%), Bermuda (0.001%)

Top importers of Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc in 2023

The world's largest importers of this commodity group in 2023:

USA - 25% of the world imports ($81 billion)
Germany - 11.5% ($36 billion)
Belgium - 8.3% ($26 billion)
Switzerland - 5.5% ($17.5 billion)
China - 5.31% ($16.8 billion)
France - 4.95% ($15.7 billion)

Belgium - 6.35% of Belgium's total imports in 2023 ($26 billion of $415 billion)
Ireland - 4.81% ($7.25 billion of $150 billion)
Switzerland - 4.79% ($17.5 billion of $365 billion)
Austria - 2.79% ($6.12 billion of $219 billion)
USA - 2.58% ($81 billion of $3.16 trillion)
Germany - 2.48% ($36 billion of $1.46 trillion)

According to statistics provided by the major importers, the largest flows of imports of «Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc» in 2023:

Imports to Belgium from Ireland (2.37% of the world imports, $7.55 billion according to external trade statistics of Belgium)
Imports to Belgium from Switzerland (2.21% of the world imports, $7.02 billion according to external trade statistics of Belgium)
Imports to Belgium from USA (2.21% of the world imports, $7.03 billion according to external trade statistics of Belgium)
Imports to China from Ireland (2.1% of the world imports, $6.68 billion according to external trade statistics of China)
Imports to Germany from Switzerland (2.05% of the world imports, $6.53 billion according to external trade statistics of Germany)
Imports to Germany from USA (2.28% of the world imports, $7.24 billion according to external trade statistics of Germany)
Imports to USA from Germany (3.69% of the world imports, $11.7 billion according to external trade statistics of USA)
Imports to USA from Ireland (7.13% of the world imports, $22 billion according to external trade statistics of USA)
Imports to USA from Netherlands (2.95% of the world imports, $9.38 billion according to external trade statistics of USA)
Imports to USA from Singapore (1.94% of the world imports, $6.18 billion according to external trade statistics of USA)